GS-1427

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-1427, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]